Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for OSU-6162

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug OSU-6162: Sponsors, patents, clinical trial progress

OSU-6162 is an investigational drug.

There have been 6 clinical trials for OSU-6162. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2007.

The most common disease conditions in clinical trials are Neuroma, Oligodendroglioma, and Thrombosis. The leading clinical trial sponsors are Ohio State University, University of Minnesota - Clinical and Translational Science Institute, and Massachusetts Eye and Ear Infirmary.

Recent Clinical Trials for OSU-6162
Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in HumansWashington University School of MedicinePhase 2
Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and MeningiomaJohns Hopkins UniversityPhase 0
Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and MeningiomaMayo ClinicPhase 0

See all OSU-6162 clinical trials

Clinical Trial Summary for OSU-6162

Top disease conditions for OSU-6162
Top clinical trial sponsors for OSU-6162

See all OSU-6162 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.